Create a Balance Sheet, Profit and Loss Statement, Closing Entries, and Post Trial Balance

Accounts Payable 922,200

Accounts Receivable 723,300

Cash 141,100

Common Stock 454,900

Cost of Goods sold 9,501,400

Debt Investments, short-term 382,600

Equipment 921,000

Accumulated Depreciation--Equipment 36,000

Goodwill 202,700

Income Tax Expense 30,500

Income Tax Payable 7,200

Interest Expense 1,500

Inventory 1,636,500

Mortgage Payable 451,500

Notes Payable, due in 6 months 784,600

Notes Payable, due in 3 years 50,500

Retained Earnings, as of December 31, 2014 1,310,400

Salaries & Wages Expense 2,933,600

Sales Revenue 12,456,900

Note: for statistical mechanics problems, you may use the following numbers of congurations] microstates depending on the phase of the system (ideal gas, 9, liquid, 1, or solid, 5): 1. Communal Entropy. The difference in entropy upon melting of a solid is commonly referred to as the "communal entropy," and for a crystalline solid is predominantly due to the difference in congurational entropy of the resulting liquid (denoted by I) compared to the initial solid (denoted by s): rms 2' sdlsconfig = configJ Sconfig Use statistical mechanics to find a simple expression for drugs by assuming that the molar (or molecular) volume of the solid and liquid are approximately equal. Hint: you will need to employ Stirling's formula (Equation 1.? in Simon 9 McQuarrfe). the electron geometry, the molecular geometry, and the polarity. SF : For geometries. use the table in Appendix F. This PhET simulation may be useful. For polarity, type "polar" or \"nonpoiar\" in the box, as appropriate. Question 3 For the following molecule. indicate the number of yalence electron, the electron geometry, the molecular geometry, and the polarity. OFE : ; ; For geometries, use the table in Appendix F. This PhET simulation may be useful. Far polarity, type "polar" or \"nonpoiar\" in the box, as appropriate. 13. You are a scientist at Merck and your annual progress report is coming up soon. Unfortunately, you have gotten nothing done over the past year and are running out of time. Your target is a large enzyme whose crystal structure has been previously screened in earlier drug design campaigns, and molecular dynamics simulations have been run for this enzyme. What would be the best course of action to take in the limited time you have left? A. Run a standard precision (SP) virtual screen on the crystal structure B. Run several XP virtual screens on previously-obtained conformations obtained from molecular dynamics simulations run on the crystal structure C. Run a SP virtual screen on conformations obtained from molecular dynamics simulations run on the crystal structure D. Begin high-throughput screening on the enzyme E. Start with a high-throughput screen on the enzyme, followed by a SP virtual screen on conformations obtained from molecular dynamics simulations run on the crystal structure